Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
Cytometry. Part B, Clinical Cytometry|September 8, 2020
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemiaGaurav Chatterjee, Harshini Sriram, Sitaram Ghogale, et al.
Frontiers in Oncology|May 12, 2020
Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 PatientsPrashant R Tembhare, Gaurav Narula, Twinkle Khanka, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2010
Prognostic factors and outcome in Askin-Rosai tumor: a review of 104 patientsSiddhartha Laskar, Chandrika Nair, Suman Mallik, et al.
Pediatric Blood & Cancer|July 2, 2021
Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trialMaya Prasad, Sneha Tandon, Rajul Gala, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
The Lancet. Oncology|January 15, 2024
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trialJyoti Bajpai, Venkatesh Kapu, Sushmita Rath, et al.
Cytometry. Part B, Clinical Cytometry|June 15, 2019
A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-10<sup>6</sup> and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 PatientsPrashant R Tembhare, Papagudi G Subramanian Pg, Sitaram Ghogale, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapySiddhartha Laskar, Gaurav Bahl, Maryann Muckaden, et al.
Pageof 15